Skip to content

Comparative Study Between High Flow Nasal Cannula And Non-invasive Ventilation In Patients With Acute Exacerbation Of Chronic Obstructive Pulmonary Disease With Moderate Type 2 Respiratory Failure (Randomized Clinical Trial)

Comparative Study Between High Flow Nasal Cannula And Non-invasive Ventilation In Patients With Acute Exacerbation Of Chronic Obstructive Pulmonary Disease With Moderate Type 2 Respiratory Failure (Randomized Clinical Trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202512499151805
Enrollment
58
Registered
2025-12-11
Start date
2025-01-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory

Interventions

Sponsors

Menoufia University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1- Patients with AECOPD with moderate hypercapnic respiratory failure(pH ranges between 7.25 and 7.35 and a PaCO2 = 50 mmHg). 2 - The patient should be conscious, alert, and cooperative.

Exclusion criteria

Exclusion criteria: 1- Age 0.5). 4 - Significant hypercapnia with pH = 7.20. 5- Severe dyspnea (RR = 40 breaths/min). 6- Glasgow coma score < 8. 7- Contraindications to NIV or HFNC As: A- Poor sputum excretion ability. B- Oral or facial trauma. C- Significant hemodynamic instability. D- Poor short-term prognosis (those already receiving palliative care or at very E -high risk of death within seven days due to existing medical/surgical pathology). F- Presence of a tracheostomy

Design outcomes

Primary

MeasureTime frame
Assessment of the treatment failure rate (which is defined as invasive ventilation or a switch in respiratory treatment modality).

Secondary

MeasureTime frame
Analysis of the following data: • ICU mortality. • ICU length of stay. • Timing of intubation. • The duration of respiratory support. • Arterial blood gas analysis (pH, PaCO2, and PaO2/FiO2) and vital signs (RR, heart rate, and blood pressure).

Countries

Egypt

Contacts

Public ContactRabab Mohammed Habeeb

Assistant professor of anesthesiology and intensive care. Faculty of medicine. Menoufia University

rabab_habeeb@med.menofia.edu.eg+201001970973

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026